AVITA Medical, Inc. Gains 48.25%

AVITA Medical, Inc. (RCEL:NASDAQ) shot up at $6.76, a gain of 48.2%. On Mon, Sep 15, 2025, RCEL:NASDAQ hit a New 2-Week High of $6.76. The stock got featured on our News Catalysts scanner on Mon, Sep 15, 2025 at 05:31 PM in the 'BIOTECH' category. From Tue, Sep 02, 2025, the stock recorded 33.33% Up Days and 50.00% Green Days

About AVITA Medical, Inc. (RCEL:NASDAQ)

Avita Medical is a single product company, the RECELL system, an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes thus avoiding or reducing the need for skin grafts. The device is approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft tissue wounds and vitiligo underway. It is currently in roll-out across the approximately 132 burn centres in the U.S. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories. It is expected to gain approval and launch in Japan via distribution partner Cosmotec shortly. In addition to its ASX listing, Avita listed on the Nasdaq in November 2019.